Learn about CVE-2022-1179, a vulnerability in openemr/openemr that allows non-privileged users to create new rules, resulting in stored cross-site scripting. Mitigation steps provided.
A detailed analysis of CVE-2022-1179, involving the vulnerability in openemr/openemr that allows a non-privileged user to create a new rule leading to stored cross-site scripting.
Understanding CVE-2022-1179
This section will cover the essential aspects related to CVE-2022-1179.
What is CVE-2022-1179?
CVE-2022-1179 involves a flaw in openemr/openemr that permits a non-privileged user to generate a new rule, ultimately resulting in stored cross-site scripting.
The Impact of CVE-2022-1179
The vulnerability poses a medium severity risk, with a CVSS base score of 4.6. It has low impact on confidentiality and integrity, with low privileges required for exploitation.
Technical Details of CVE-2022-1179
This section will delve into the specifics of the CVE-2022-1179 vulnerability.
Vulnerability Description
The vulnerability allows non-privileged users to create a new rule, leading to stored cross-site scripting in openemr/openemr versions prior to 6.0.0.4.
Affected Systems and Versions
The issue impacts the GitHub repository openemr/openemr, specifically versions less than 6.0.0.4 with custom version types.
Exploitation Mechanism
Attackers can exploit this vulnerability over a network with low complexity, requiring user interaction. It does not impact availability and has a scope of 'UNCHANGED'.
Mitigation and Prevention
In this section, we outline the steps to mitigate and prevent exploitation of CVE-2022-1179.
Immediate Steps to Take
Users should upgrade to version 6.0.0.4 or later to prevent the risk of stored cross-site scripting by non-privileged users.
Long-Term Security Practices
Maintaining proper input validation mechanisms and regular security audits can help prevent such vulnerabilities in the long term.
Patching and Updates
Vendors should release patches promptly to address this issue and enhance the security of openemr/openemr.